Company offers tips for customers to manage rising temperatures and energy costs READING, Pa., June 20, 2022 /PRNewswire/ — With the hot, humid summer months expected to produce higher electric usage and potentially severe weather, Met-Ed, a FirstEnergy Corp. (NYSE: FE) subsidiary, is…
Related Posts
FREESTONE ANNOUNCES CLOSING OF GROWTH FINANCING FOR ELEMENTAL RECYCLING
DALLAS, Aug. 2, 2022 /PRNewswire/ — Freestone Holdco, LLC (“Freestone”), a portfolio company of Tailwater Capital LLC (“Tailwater”), today announced…
Industrial Automation Co. Ranks #110 on the 2022 Inc. 5000 List of America’s Fastest-Growing Private Companies, #4 in NC
Inc. 5000 Honorees Represent the Fastest Growing Companies in America, Showing the Continued Success of Industrial Automation Co. in Supplying…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.